Rationale for Treatment of Metastatic Squamous Cell Carcinoma of the Lung Using Fibroblast Growth Factor Receptor InhibitorsGÖKE, Friederike; FRANZEN, Alina; GERIGK, Ulrich et al.Chest (American College of Chest Physicians). 2012, Vol 142, Num 4, pp 1020-1026, issn 0012-3692, 7 p.Article

Rearrangement of the ETS genes ETV-1, ETV-4, ETV-5, and ELK-4 is a clonal event during prostate cancer progressionSHAIKHIBRAHIM, Zaki; BRAUN, Martin; NIKOLOV, Pavel et al.Human pathology. 2012, Vol 43, Num 11, pp 1910-1916, issn 0046-8177, 7 p.Article

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancerPEIFER, Martin; FERNANDEZ-CUESTA, Lynnette; MENON, Roopika et al.Nature genetics. 2012, Vol 44, Num 10, pp 1104-1110, issn 1061-4036, 7 p.Article

Relevance of cohort design for studying the frequency of the ERG rearrangement in prostate cancerBRAUN, Martin; SCHEBLE, Veit J; STENZL, Arnulf et al.Histopathology. 2011, Vol 58, Num 7, pp 1028-1036, issn 0309-0167, 9 p.Article

MED15, encoding a subunit of the mediator complex, is overexpressed at high frequency in castration-resistant prostate cancerSHAIKHIBRAHIM, Zaki; MENON, Roopika; SVENSSON, Maria et al.International journal of cancer (Print). 2014, Vol 135, Num 1, pp 19-26, issn 0020-7136, 8 p.Article

Frequency and clinicopathologic correlates of KRAS amplification in non-small cell lung carcinomaWAGNER, Patrick L; STIEDL, Ann-Cathrin; MOCH, Holger et al.Lung cancer. 2011, Vol 74, Num 1, pp 118-123, issn 0169-5002, 6 p.Article

SOX2 amplification is a common event in squamous cell carcinomas of different organ sitesMAIER, Sebastian; WILBERTZ, Theresia; MOCH, Holger et al.Human pathology. 2011, Vol 42, Num 8, pp 1078-1088, issn 0046-8177, 11 p.Article